BQ
BoardQBank
CONO Pharmacotherapy Safety
DashboardPractice QuestionsModalities

Pharmacotherapy Safety

CONO-2 pharmacotherapy safety question bank generated from the uploaded PDF. Focus: prescribing scope, medication reconciliation, renal/hepatic dosing, interactions, adverse reactions, emergency red flags, pregnancy safety, older adult risk, and Health Canada reporting.

PDF MCQs loaded: 120Current view: 40 questionsA–E CONO style
120Total loaded from PDF
40Current view
0%Current score
0Answered

Part and Filters

Pharmacotherapy PDF
1–4041–8081–120All Questions
Allergy / Anaphylaxis / Emergency Safety: 1Analgesics / Anti-inflammatory Safety: 3Antibiotic / Antiseizure / Narrow-Index Safety: 4Anticoagulant / Bleeding Risk: 3CONO Scope / Prescribing Standard: 3Diabetes Pharmacotherapy Safety: 2Natural Health Product Interactions: 1Opioid / CNS Depression: 4Pharmacotherapy Safety: 6Pharmacovigilance / Reporting: 1Pregnancy / Contraception / Vaccine Safety: 7Psychotropic / Serotonin / QT Safety: 2Renal Dosing / Accumulation: 3

Question

Choose your answer

Review mode shows explanations

BoardQBank Review

Pharmacotherapy Safety Quick Review

Core processBPMH / medication reconciliation
Allergy vs intolerance documentation
Renal and hepatic function review
Scope verification before prescribing
High-risk combinationsACE inhibitor/ARB + diuretic + NSAID
Warfarin/DOAC + NSAID or interacting antibiotic
SSRI + NSAID bleeding risk
Opioid + benzodiazepine + alcohol
Emergency red flagsAnaphylaxis or angioedema
Melena or active bleeding
Serotonin toxicity with clonus
Rhabdomyolysis with dark urine
Hyperkalemia with palpitations
CONO / reporting trapsOntario scope cannot be expanded by consent
Health Canada reporting requires suspected serious reaction, not proven causality

Calculator

Result appears here.